Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022

This article has now been updated. Please use the final version.

Author information

Mariko Harada-Shiba
Cardiovascular Center, Osaka Medical and Pharmaceutical University
Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute
Hidenori Arai
National Center for Geriatrics and Gerontology
Hirotoshi Ohmura
Department of Cardiovascular Biology and Medicine, Juntendo University, School of Medicine
Hiroaki Okazaki
Division of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University
Daisuke Sugiyama
Faculty of Nursing And Medical Care, Keio University
Hayato Tada
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine
Kazushige Dobashi
Department of Pediatrics, School of Medicine, University of Yamanashi
Kota Matsuki
Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine
Tetsuo Minamino
Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
Shizuya Yamashita
Department of Cardiology, Rinku General Medical Center
Koutaro Yokote
Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine
Joint Working Group of the Japan Atherosclerosis Society for the Development of Guidelines for the Treatment of Adult Familial Hypercholesterolemia

JOURNAL OPEN ACCESS Advance online publication

Article ID: CR005

Details